Global Veterinary Dermatology Drugs Market Size study, by Animal type (Companion, Livestock) by Route of Administration, by Indication, by Distribution Channel and Regional Forecasts 2021-2027
- Category: Healthcare
- Published Date: Oct 2021
- Publisher: Bizwit Research
- Pages: 200
Global Veterinary Dermatology Drugs Market is valued approximately USD 7.4 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 9.3 % over the forecast period 2021-2027. Veterinary Dermatology Drugs are the drugs used in the treatment of skin diseases in animals. Rising health expenditure on pets has led the adoption of Veterinary Dermatology Drugs across the forecast period. For instance, according to the Pet Products Association, the overall expenditure in the US PET Industry increased to USD 95.7 billion in 2019 from USD 90.5 billion in 2018. (Increase in prevalence of skin diseases in animals) However, Lack of awareness in developing regions impedes the growth of the market over the forecast period of 2021-2027. Also, with the increase in expenditure in research and development has led the adoption & demand for Veterinary Dermatology Drugs Market. is likely to increase the market growth during the forecast period.
The regional analysis of global Veterinary Dermatology Drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World . North America is a significant region across the world in terms of market share owing to the initiatives by the government . Whereas, Asia-Pacific is anticipated to exhibit highest growth rateover the forecast period 2021-2027. Factors such as increase in expenditure on pets would create lucrative growth prospects for the Veterinary Dermatology Drugsmarket across Asia-Pacific region.
Major market player included in this report are:
Elanco
Vetoquinol S.A
ceva
Merck n Co.Inc
Zoetis
Vibrac
Bimeda, Inc
Vivaldis
Bioiberica S.A.U
Indian Immunological
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Animal type:
Companion
Livestock
By Route of Administration:
By Indication:
By Distribution Channel:
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027
Target Audience of the Global Veterinary Dermatology Drugs Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
The regional analysis of global Veterinary Dermatology Drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World . North America is a significant region across the world in terms of market share owing to the initiatives by the government . Whereas, Asia-Pacific is anticipated to exhibit highest growth rateover the forecast period 2021-2027. Factors such as increase in expenditure on pets would create lucrative growth prospects for the Veterinary Dermatology Drugsmarket across Asia-Pacific region.
Major market player included in this report are:
Elanco
Vetoquinol S.A
ceva
Merck n Co.Inc
Zoetis
Vibrac
Bimeda, Inc
Vivaldis
Bioiberica S.A.U
Indian Immunological
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Animal type:
Companion
Livestock
By Route of Administration:
By Indication:
By Distribution Channel:
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027
Target Audience of the Global Veterinary Dermatology Drugs Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Global Veterinary Dermatology Drugs Market, by Region, 2019-2027 (USD Billion)
1.2.2. Global Veterinary Dermatology Drugs Market, by Animal type, 2019-2027 (USD Billion)
1.2.3. Global Veterinary Dermatology Drugs Market,by Route of Administration, 2019-2027 (USD Billion)
1.2.4. Global Veterinary Dermatology Drugs , Market,by Indication, 2019-2027 (USD Billion)
1.2.5. Global Veterinary Dermatology Drugs Market, by Distribution channel, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Veterinary Dermatology Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Veterinary Dermatalogy Drugs Market Dynamics
3.1. Veterinary Dermatalogy Drugs Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increase in prevalence of skin diseases in animals
3.1.1.2. Rising health expenditure on pets
3.1.2. Market Challenges
3.1.2.1. Side effects of the drugs
3.1.3. Market Opportunities
3.1.3.1. Increasing prevalence of pet ownership
Chapter 4. Global Veterinary Dermatology Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Veterinary Dermatology Drugs Market Market, by Animal type
5.1. Market Snapshot
5.2. Global Veterinary Dermatology Drugs Market Market by Animal type, Performance - Potential Analysis
5.3. Global Veterinary Dermatology Drugs Market Market Estimates & Forecasts by Animal type 2018-2027 (USD Billion)
5.4. Veterinary Dermatology Drugs Market Market, Sub Segment Analysis
5.4.1. Companion
5.4.2. Livestock
Chapter 6. Global Veterinary Dermatology Drugs Market, by Route of Administration
6.1. Market Snapshot
6.2. Global Veterinary Dermatology Drugs Market by Route of Administration, Performance - Potential Analysis
6.3. Global Veterinary Dermatology Drugs Market Estimates & Forecasts by Route of Administration 2018-2027 (USD Billion)
Chapter 7. Global Veterinary Dermatology Drugs Market, by Indication
7.1. Market Snapshot
7.2. Global Veterinary Dermatology Drugs Market by Indication, Performance - Potential Analysis
7.3. Global Veterinary Dermatology Drugs Market Estimates & Forecasts by Indication 2018-2027 (USD Billion)
Chapter 8. Global Veterinary Dermatology Drugs Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Veterinary Dermatology Drugs Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Veterinary Dermatology Drugs Market Estimates & Forecasts by Distribution Chanel 2018-2027 (USD Billion)
Chapter 9. Global Veterinary Dermatology Drugs Market Regional Analysis
9.1. Veterinary Dermatology Drugs Market t, Regional Market Snapshot
9.2. North America Veterinary Dermatology Drugs Market
9.2.1. U.S. Veterinary Dermatology Drugs Market
9.2.1.1. Animal type breakdown estimates & forecasts, 2018-2027
9.2.1.2. Route of administration breakdown estimates & forecasts, 2018-2027
9.2.1.3. Indication breakdown estimates & forecasts, 2018-2027
9.2.1.4. Distribution Channel breakdown estimates & forecasts, 2018-2027
9.2.2. Canada Veterinary Dermatology Drugs Market
9.3. Europe Veterinary Dermatology Drugs Market Market Snapshot
9.3.1. U.K. Veterinary Dermatology Drugs Market
9.3.2. Germany Veterinary Dermatology Drugs Market
9.3.3. France Veterinary Dermatology Drugs Market
9.3.4. Spain Veterinary Dermatology Drugs Market
9.3.5. Italy Veterinary Dermatology Drugs Market
9.3.6. Rest of Europe Veterinary Dermatology Drugs Market
9.4. Asia-Pacific Veterinary Dermatology Drugs Market Snapshot
9.4.1. China Veterinary Dermatology Drugs Market
9.4.2. India Veterinary Dermatology Drugs Market
9.4.3. Japan Veterinary Dermatology Drugs Market
9.4.4. Australia Veterinary Dermatology Drugs Market
9.4.5. South Korea Veterinary Dermatology Drugs Market
9.4.6. Rest of Asia Pacific Veterinary Dermatology Drugs Market
9.5. Latin America Veterinary Dermatology Drugs Market Snapshot
9.5.1. Brazil Veterinary Dermatology Drugs Market
9.5.2. Mexico Veterinary Dermatology Drugs Market
9.6. Rest of The World Veterinary Dermatology Drugs Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Elanco
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Vetoquinol S.A
10.2.3. ceva
10.2.4. Merk n Co.Inc
10.2.5. Zoetis
10.2.6. Vibrac
10.2.7. Bimeda, Inc
10.2.8. Vivaldis
10.2.9. Bioiberica S.A.U
10.2.10. Indian Immunologicals
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Global Veterinary Dermatology Drugs Market, by Region, 2019-2027 (USD Billion)
1.2.2. Global Veterinary Dermatology Drugs Market, by Animal type, 2019-2027 (USD Billion)
1.2.3. Global Veterinary Dermatology Drugs Market,by Route of Administration, 2019-2027 (USD Billion)
1.2.4. Global Veterinary Dermatology Drugs , Market,by Indication, 2019-2027 (USD Billion)
1.2.5. Global Veterinary Dermatology Drugs Market, by Distribution channel, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Veterinary Dermatology Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Veterinary Dermatalogy Drugs Market Dynamics
3.1. Veterinary Dermatalogy Drugs Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increase in prevalence of skin diseases in animals
3.1.1.2. Rising health expenditure on pets
3.1.2. Market Challenges
3.1.2.1. Side effects of the drugs
3.1.3. Market Opportunities
3.1.3.1. Increasing prevalence of pet ownership
Chapter 4. Global Veterinary Dermatology Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Veterinary Dermatology Drugs Market Market, by Animal type
5.1. Market Snapshot
5.2. Global Veterinary Dermatology Drugs Market Market by Animal type, Performance - Potential Analysis
5.3. Global Veterinary Dermatology Drugs Market Market Estimates & Forecasts by Animal type 2018-2027 (USD Billion)
5.4. Veterinary Dermatology Drugs Market Market, Sub Segment Analysis
5.4.1. Companion
5.4.2. Livestock
Chapter 6. Global Veterinary Dermatology Drugs Market, by Route of Administration
6.1. Market Snapshot
6.2. Global Veterinary Dermatology Drugs Market by Route of Administration, Performance - Potential Analysis
6.3. Global Veterinary Dermatology Drugs Market Estimates & Forecasts by Route of Administration 2018-2027 (USD Billion)
Chapter 7. Global Veterinary Dermatology Drugs Market, by Indication
7.1. Market Snapshot
7.2. Global Veterinary Dermatology Drugs Market by Indication, Performance - Potential Analysis
7.3. Global Veterinary Dermatology Drugs Market Estimates & Forecasts by Indication 2018-2027 (USD Billion)
Chapter 8. Global Veterinary Dermatology Drugs Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Veterinary Dermatology Drugs Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Veterinary Dermatology Drugs Market Estimates & Forecasts by Distribution Chanel 2018-2027 (USD Billion)
Chapter 9. Global Veterinary Dermatology Drugs Market Regional Analysis
9.1. Veterinary Dermatology Drugs Market t, Regional Market Snapshot
9.2. North America Veterinary Dermatology Drugs Market
9.2.1. U.S. Veterinary Dermatology Drugs Market
9.2.1.1. Animal type breakdown estimates & forecasts, 2018-2027
9.2.1.2. Route of administration breakdown estimates & forecasts, 2018-2027
9.2.1.3. Indication breakdown estimates & forecasts, 2018-2027
9.2.1.4. Distribution Channel breakdown estimates & forecasts, 2018-2027
9.2.2. Canada Veterinary Dermatology Drugs Market
9.3. Europe Veterinary Dermatology Drugs Market Market Snapshot
9.3.1. U.K. Veterinary Dermatology Drugs Market
9.3.2. Germany Veterinary Dermatology Drugs Market
9.3.3. France Veterinary Dermatology Drugs Market
9.3.4. Spain Veterinary Dermatology Drugs Market
9.3.5. Italy Veterinary Dermatology Drugs Market
9.3.6. Rest of Europe Veterinary Dermatology Drugs Market
9.4. Asia-Pacific Veterinary Dermatology Drugs Market Snapshot
9.4.1. China Veterinary Dermatology Drugs Market
9.4.2. India Veterinary Dermatology Drugs Market
9.4.3. Japan Veterinary Dermatology Drugs Market
9.4.4. Australia Veterinary Dermatology Drugs Market
9.4.5. South Korea Veterinary Dermatology Drugs Market
9.4.6. Rest of Asia Pacific Veterinary Dermatology Drugs Market
9.5. Latin America Veterinary Dermatology Drugs Market Snapshot
9.5.1. Brazil Veterinary Dermatology Drugs Market
9.5.2. Mexico Veterinary Dermatology Drugs Market
9.6. Rest of The World Veterinary Dermatology Drugs Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Elanco
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Vetoquinol S.A
10.2.3. ceva
10.2.4. Merk n Co.Inc
10.2.5. Zoetis
10.2.6. Vibrac
10.2.7. Bimeda, Inc
10.2.8. Vivaldis
10.2.9. Bioiberica S.A.U
10.2.10. Indian Immunologicals
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
no record found